Akorn, Inc.: Drug Recall

Recall #D-0786-2021 · 08/02/2021

Class II: Risk

Recall Details

Recall Number
D-0786-2021
Classification
Class II
Product Type
Drug
Recalling Firm
Akorn, Inc.
Status
Terminated
Date Initiated
08/02/2021
Location
Lake Forest, IL, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
142,188 tubes

Reason for Recall

Non-Sterility - OOS sterility testing observed during 12-month controlled room temperature stability testing. The microbiological investigation identified the organism as a member of the Bacillus cereus group.

Product Description

Artificial Tears Ointment, Lubricant Eye Ointment, Net Wt. 3.5 g (1/8 oz.) per tube, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-062-35

Distribution Pattern

Nationwide USA and Puerto Rico

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.